Securing comparator drugs in the EU is a complex process shaped by availability constraints, regulatory expectations, and competitive market behavior. But if we have the right planning, strong ...

DCN Dx, a specialist in diagnostics development, manufacturing, regulatory consulting, and clinical research, today announced the launch of a new prospective biospecimen collections offering, ...

The ISPOR Glasgow panel conveyed a constructive, forward looking mood: JCA can work – and work better over time – if ...

The Financial Conduct Authority (FCA) has published updated proposals to its Value for Money (VFM) Framework consultation.

IM1240 demonstrated improved safety in a toxicology study at doses up to 300-fold higher than a non-capped comparator ...

Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.

Nigeria's average fertility is 4.8 children per woman in 2024, down from 5.3 in 2018, with dramatic regional variations.

The UK government and trust-based pensions regulator have backed new value for money proposals for the defined contribution ...

After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than ...

Financial Conduct Authority (FCA), and The Pensions Regulator (TPR) have launched a consultation on the value for money (VfM) ...

Union argued requirement contradicted collective agreement, disproportionately affected employees on maternity leave ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ...